Navigation Links
Coca-Cola Sued Over Deceptive VitaminWater Claims
Date:1/15/2009

Class Action Lawsuit Alleges Deceptive Advertising Claims

NEW YORK, Jan. 15 /PRNewswire/ -- A class action lawsuit was filed late yesterday in the United States District Court for the Northern District of California against the Coca-Cola Company alleging that Coca-Cola has used deceptive advertising in marketing its VitaminWater line of beverages. The plaintiff is represented by Whatley Drake & Kallas, LLC ("WDK"), Reese Richman LLP, and the Center for Science in the Public Interest (CSPI).

The complaint alleges that Coca-Cola deceived consumers by marketing VitaminWater as a healthy alternative to soft drinks formulated to provide a host of health benefits including reducing the risk of certain diseases, promoting healthy joints, and supporting optimal immune function. Contrary to Coca-Cola's claims of health benefits, the complaint alleges that the 33 grams of sugar in each bottle of VitaminWater may contribute to serious health problems, such as obesity and diabetes.

"Consumers are increasingly health-conscious, with more and more people avoiding soft drinks in favor of healthier alternatives," said WDK attorney Patrick Sheehan. "Coca-Cola has taken advantage of that trend -- and of consumers -- by purposefully misrepresenting their product as 'healthy' when in fact it is essentially sugar water with a few added vitamins. Consumers should not have to look beyond the misleading claims on VitaminWater labels in order to discover the truth on an ingredients list."

VitaminWater does not name Coca-Cola anywhere on its packaging or labeling, instead marketing these purportedly healthy drinks without any reference to the soft drink manufacturer that produces them.

"It's clear that Coca-Cola has attempted to market an alternative to its soda products in a way that deliberately deceives consumers," continued Sheehan. "Whatley Drake & Kallas is proud to be playing a role in protecting those consumers through this class action suit filed on their behalf."

WDK is a 35-attorney law firm with offices in New York, Birmingham and Boston that primarily represents consumers, injured workers, unions and small businesses and is known for its work on class action suits, including recent products liability cases involving lead-contaminated toys sold by Mattel and baby bottles containing the dangerous chemical bisphenol-A sold by a variety of manufacturers. In November, 2007, WDK was named to the prestigious National Law Journal's Plaintiffs' Hot List.


'/>"/>
SOURCE Whatley, Drake & Kallas, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated
2. Pennsylvania Attorney General Corbett Announces a Multi-State, $7 Million Settlement With Airborne Health, Inc., Over Charges of Deceptive Advertising
3. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
4. Information About The Airborne Health, Inc. Settlement, and Other Ongoing Litigation Alleging False and Deceptive Marketing Of Airborne(R)
5. Consumer Alert: Cancer Project Organization Is a Deceptive Animal Rights Group
6. AMA Claims Victory With Record Breaking Settlement in Case Against Insurer
7. The Doctors Company Launches Southeast Legal Summit to Provide Industry's Best Claims Defense for Physicians
8. Summa Health Network Announces Contract with MDdatacor to Support Multi-Insurer Health Care Quality Initiative; Initiative to Use Clinical Data to Supplement Claims Data and Enhance Outcomes
9. The Doctors Company Launches Southeast Legal Summit to Provide Industry's Best Claims Defense for Physicians
10. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
11. Genesis Pharmaceuticals Files Counter Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... office, will speak at the American Conference Institute’s 21st Drug & Medical Device ... a Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical ...
(Date:12/2/2016)... ... 2016 , ... Advanced Inc., a leading provider of travel therapy and travel ... serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served ... and operational leadership experience to Advanced Inc. He began his career in finance at ...
(Date:12/2/2016)... PITTSBURGH, PA (PRWEB) , ... December 02, 2016 , ... ... or struggling through rehabilitation of an injury, patients must find the one that works ... for his pain, he created a machine that worked and decided to share it ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... 5,251.11, down 1.36%; the Dow Jones Industrial Average edged 0.36% ... at 2,191.08, down 0.35%. Losses were broad based as six ... Stock-Callers.com has initiated research reports on the following Services equities: ... (NASDAQ: QGEN ), INC Research Holdings Inc. (NASDAQ: ...
(Date:12/2/2016)... , Dec. 1, 2016 Around the ... country, region and each habitable land present over earth. ... every individual once in a life time this is ... care available until now. Given the steady increase in ... together with the spiraling healthcare costs of treatment, there ...
(Date:12/2/2016)... The iShares Nasdaq Biotechnology Exchange-Traded Fund ... victory early in November. Less political risk has boosted ... predicting an uptick in M&A activities. Today, Stock-Callers.com takes ... they have fared at the last close: Celldex Therapeutics ... (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. (NYSE ...
Breaking Medicine Technology: